BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17212777)

  • 1. Discrete conformational changes as regulators of the hydrolytic properties of beta-amyloid (1-40).
    Brzyska M; Trzesniewska K; Gers T; Elbaum D
    FEBS J; 2006 Dec; 273(24):5598-611. PubMed ID: 17212777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
    J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation of Abeta(1-42) in the presence of short peptides: conformational studies.
    Laczkó I; Vass E; Soós K; Fülöp L; Zarándi M; Penke B
    J Pept Sci; 2008 Jun; 14(6):731-41. PubMed ID: 18247430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of amyloid beta peptide fragment (25-35) in different microenvironments.
    Shanmugam G; Jayakumar R
    Biopolymers; 2004; 76(5):421-34. PubMed ID: 15468066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region.
    Laczkó I; Holly S; Kónya Z; Soós K; Varga JL; Hollósi M; Penke B
    Biochem Biophys Res Commun; 1994 Nov; 205(1):120-6. PubMed ID: 7999011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
    Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.
    Maji SK; Amsden JJ; Rothschild KJ; Condron MM; Teplow DB
    Biochemistry; 2005 Oct; 44(40):13365-76. PubMed ID: 16201761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants.
    Juszczyk P; Kołodziejczyk AS; Grzonka Z
    J Pept Sci; 2009 Jan; 15(1):23-9. PubMed ID: 19023881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
    Jun S; Gillespie JR; Shin BK; Saxena S
    Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary structure conversions of Alzheimer's Abeta(1-40) peptide induced by membrane-mimicking detergents.
    Wahlström A; Hugonin L; Perálvarez-Marín A; Jarvet J; Gräslund A
    FEBS J; 2008 Oct; 275(20):5117-28. PubMed ID: 18786140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between amyloid beta-protein aggregates and membranes.
    Kakio A; Yano Y; Takai D; Kuroda Y; Matsumoto O; Kozutsumi Y; Matsuzaki K
    J Pept Sci; 2004 Oct; 10(10):612-21. PubMed ID: 15526710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of amyloid beta fragments in aqueous environments.
    Takano K; Endo S; Mukaiyama A; Chon H; Matsumura H; Koga Y; Kanaya S
    FEBS J; 2006 Jan; 273(1):150-8. PubMed ID: 16367755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.